Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - CRISPR Therapeutics AG | StockGist | StockGist

Companies
CRSP
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CRSPSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

CRISPR Therapeutics AG

Filed Jan 10, 2025

Accepted Jan 9, 2025, 7:00 PM ET

CIK 0001674416

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

CRISPR Therapeutics AG

Person Type

IA

Amendment History

6 filings

SCHEDULE 13G
Original
Nov 14, 20250000940594-25-000008
SCHEDULE 13G/A
Amendment 1
Viewing
Jan 10, 20250001104659-25-002717
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250001104659-25-013688
SCHEDULE 13G/A
Amendment 3
May 13, 20250001562230-25-000068
SCHEDULE 13G/A
Amendment 4
May 14, 20250001104659-25-048312
SCHEDULE 13G/A
Amendment 5
Latest
Feb 17, 20260000940594-26-000006

Recent Filings

CRISPR Therapeutics AG3 weeks ago

CRISPR Therapeutics AG1 months ago

CRISPR Therapeutics AG1 months ago

CRISPR Therapeutics AG1 months ago

CRISPR Therapeutics AG1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice